Spread of a disease inside a body
POPULARITY
Categories
368 episodes with metastatic
58 episodes with metastatic
123 episodes with metastatic
39 episodes with metastatic
21 episodes with metastatic
19 episodes with metastatic
26 episodes with metastatic
23 episodes with metastatic
33 episodes with metastatic
32 episodes with metastatic
31 episodes with metastatic
17 episodes with metastatic
19 episodes with metastatic
16 episodes with metastatic
15 episodes with metastatic
13 episodes with metastatic
22 episodes with metastatic
13 episodes with metastatic
13 episodes with metastatic
10 episodes with metastatic
13 episodes with metastatic
8 episodes with metastatic
12 episodes with metastatic
11 episodes with metastatic
12 episodes with metastatic
13 episodes with metastatic
14 episodes with metastatic
10 episodes with metastatic
8 episodes with metastatic
21 episodes with metastatic
9 episodes with metastatic
13 episodes with metastatic
10 episodes with metastatic
11 episodes with metastatic
17 episodes with metastatic
6 episodes with metastatic
9 episodes with metastatic
9 episodes with metastatic
9 episodes with metastatic
5 episodes with metastatic
9 episodes with metastatic
10 episodes with metastatic
9 episodes with metastatic
10 episodes with metastatic
12 episodes with metastatic
10 episodes with metastatic
3 episodes with metastatic
11 episodes with metastatic
5 episodes with metastatic
5 episodes with metastatic
6 episodes with metastatic
6 episodes with metastatic
8 episodes with metastatic
5 episodes with metastatic
Today's conversation is a deeply personal look at what it means to be diagnosed with breast cancer at just 30 years old. We often hear the statistics that more young women are being diagnosed, but numbers can't capture the shock of finding a lump before you think you're even old enough to worry… or the life-altering shift that happens when you are put into medically induced menopause. Caroline McNally knows the struggles of being in the thick of treatment and the isolation of being diagnosed younger than most. But she also knows about strength, hope and learning how to advocate for herself and others.
I'm Still Here: Lessons from Life with Metastatic Breast Cancer with Heather Jose
Last week in Part 1, I shared the story of being diagnosed with metastatic (stage 4) breast cancer at just 26 years old — the shock, fear, and life-altering moment that changed everything.In Part 2, I talk about what came next.After living with metastatic disease for 27 years, my perspective on life, time, fear, and what truly matters has shifted in ways I never expected.This episode is about:• learning to live fully inside uncertainty• letting go of waiting for life to feel safe• naming the hard stuff without being consumed by it• and discovering meaning alongside ongoing treatmentIt's not about staying positive.It's about staying present.If you're living with cancer, loving someone who is, or navigating a season of life that feels uncertain or heavy, I hope this conversation reminds you that life can still be meaningful — even here.Available Now!
Welcome to Season 2 of the Orthobullets Podcast.In this episode, we review the high-yield topic of Metastatic Disease of Extremity from the Pathology section.Follow Orthobullets on Social Media:FacebookInstagramTwitterLinkedInYouTube
Treatment is a significant part of overcoming breast cancer, but what about the mental, physical and emotional challenges this disease presents? Sarah Cipolla and Tawana Davis both relied on their faith to get through breast cancer. Through it all – the ups and downs and good times and setbacks – they had hope for better days and trusted in their faith. Hope and faith are powerful forces during challenging times. Susan G. Komen leads Worship in Pink, a nationwide program that brings breast health education to faith communities. Through this effort, Komen can reach people who don't participate in breast health care and people who rely on their faith to overcome life's challenges. Thanks to Merck and Novartis for supporting the Worship in Pink Program
Send us a textJoin us is as we celebrate Kidney Cancer week with a Masterclass walk through metastatic Renal Cancer with Professor Ricky Frazer from Velindre Cancer Centre.Ricky is a co-host of the hugely successful Immunobuddies podcast and has a vast experience in immunotherapy management.We look at the indications for immunotherapy versus anti-VEGF TKI therapy.Should we just accept anti-VEGF TKI monotherapy in Favourable Risk patients?When should we try IO/IO combination versus IO/TKI combinations in the first line setting?All this whilst Ricky looks to put John in his place!!Enjoy
I'm Still Here: Lessons from Life with Metastatic Breast Cancer with Heather Jose
At 26 years old, I was diagnosed with metastatic (stage 4) breast cancer — a moment that changed everything in an instant.In Part 1 of my story, I share what led up to my diagnosis, the shock of hearing the words “stage four,” and what those early days of fear, uncertainty, and life-altering decisions were really like.This isn't a clinical cancer story.It's the human side — the emotions, the questions, the grief, and the beginning of learning how to live inside a life I never planned for.If you're newly diagnosed, supporting someone you love, or walking through something that feels overwhelming, this episode is for you.Part 2 will dive into how those early experiences shaped the way I live fully with metastatic disease today.Available Now!
Three years after finishing treatment for stage 1 breast cancer, Lea learned she had metastatic breast cancer, for which there is no cure today. Even after having to fight for an initial screening, not receiving a recommendation to start tamoxifen and not experiencing transparency from her doctor, Lea Leach kept advocating for herself and making changes be treated as a whole person. Today, she is living her life with purpose and is passionate about advocating for breast cancer awareness, particularly for women of color.
Presenter: Ryan Quigley Not all metastatic breast cancer is created equal. This AudioAbstract spotlights new data from a multicenter study in Japan that highlights how the first site of distant recurrence can significantly shape a patient's prognosis. By isolating cases with single-organ metastasis, the study draws sharp contrasts in survival based on metastatic location, revealing that patients with brain or liver involvement fare far worse than those with bone or lung metastases. Tune in to better understand how site and even biology and presentation can guide care for patients with metastatic breast cancer.
Send us a textJoin us for Part 2 of our Metastatic Endometrial Cancer special with the amazing Dr Gemma Eminowicz from University College London Hospital. In episode 1 we looked at molecular profiling and immunotherapy.In this episode we explore the role of;- hormone therapy- Antibody drug conjugates- PARP inhibitorsEndometrial cancer is taking off in terms of new and exciting treatment options.Gemma does an amazing job talking us through them.Enjoy.
In this podcast, Eric K. Singhi from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, and Eric S. Nadler from the Baylor University Medical Center, Dallas, TX, USA discuss the available treatment options for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) and focus on the efficacy and safety of first-line treatments and sequencing strategies. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast article through the Targeted Oncology website and by using this link: https://link.springer.com/article/10.1007/s11523-025-01192-y. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Welcome to the Komen Health Equity Revolution podcast series on Real Pink. Each month in this series, we bring together patients, community partners, health care providers, researchers and advocates to talk about real challenges and real solutions driving the health equity revolution. Today, we're exploring what happens when survival requires more than strength — it requires grace. Our guest, breast cancer survivor and advocate Joi White, discovered that letting go, softening and advocating for herself became the real pathway to healing. Her story is courageous, culturally resonant and deeply honest.
In this episode, UROONCO PCa Associate Editor Assoc. Prof. Pawel Rajwa (PL) interviews medical oncologist Prof. Silke Gillessen Sommer (CH) about the present and future directions of metastatic prostate cancer treatment.They discuss the greatest survival gains in metastatic prostate cancer over the past decade, triplet therapy in mHSPC and patient selection, the role of PSMA-PET imaging and sequencing of systemic therapies in metastatic prostate cancer, biomarker-driven treatment selection, and finally where the future of metastatic prostate cancer treatment is heading.Here are the links to the articles and event which were mentioned in this podcast: EORTC GUCG 2238 De-escalate trialCAPItello-281 phase III studyAPCCC (Advanced Prostate Cancer Consensus Conference)For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics: Case: A man in his early 60s with metastatic urothelial bladder cancer (mUBC) and medical history of tobacco use receives first-line enfortumab vedotin (EV) and pembrolizumab with excellent response after 3 cycles — Dr Fahey (0:00) Case: A woman in her early 80s with tumor mutational burden-high mUBC receives pembrolizumab with complete response and later discontinues after developing Grade 1 pneumonitis has no further evidence of disease — Dr Anari (9:19) Case: A man in his early 70s with mUBC who received single-agent EV develops neuropathy and hyperglycemia — Dr Anari (19:10) CME information and select publications
Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, present real patient cases on metastatic bladder cancer, with additional commentary from Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York.CME information and select publications here.
Send us a textDr Gemma Eminowicz returns for 2026!!Join us as we discuss the metastatic endometrial cancer landscape with Simply Oncology 'friend of the show' Dr Gemma Eminowicz from University College Hospital London.Advanced endometrial cancer is so much more than carboplatin and paclitaxel. It now has the complete range of oncological treatments;- Chemotherapy- Immunotherapy- Antibody Drug Conjugates- Hormone therapy- Targeted therapy- RadiotherapyWe look at how the molecular testing in endometrial cancer has shaped advanced endometrial cancer therapy.We look at the arrival of chemo-immunotherapy in the MMRd group and now in the MMRp patient group.In the MMR proficient group we discuss the merits of 1st line Chemo-immunotherapy versus sequencing treatment to allow potential VEGF targeted therapy.Gemma shares her invaluable experience and helps Mike understand advanced endometrial cancer. Enjoy!!
In this episode, we review the high-yield topic of Metastatic Brain Cancer from the Oncology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
Even after a serious diagnosis, men can still pursue decisions that protect the life they want to live. In this episode, Dr. Stephen Petteruti addresses metastatic prostate cancer with a focus on what truly shapes outcomes after the disease has spread. He explains why castration resistance often determines prognosis, how conventional pathways can accelerate decline, and why alternative strategies like bipolar testosterone therapy aim to disrupt cancer biology while supporting vitality.Survival benefit must be weighed against real-world cost. Dr. Stephen walks through chemotherapy, advanced hormone blockade, radioactive therapies, and genetic-targeted drugs, translating statistics into months lived and quality preserved. The emphasis stays on informed choice and realistic expectations.Value clarity over coercion and vitality over hollow promises. Tune in to the episode of Metastatic Prostate Cancer: What Actually Matters After the Cancer Has Spread.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: https://www.drstephenpetteruti.com/Practice: www.intellectualmedicine.comYouTube: https://www.youtube.com/@intellectualmedicineLinkedIn: https://www.linkedin.com/in/drstephenpetteruti/Instagram: https://www.instagram.com/dr.stephenpetteruti/Facebook: https://www.facebook.com/dr.stephenpetterutiMen's Vitality Community: https://www.intellectualmedicine.com/membership Consult with Dr. Petteruti: https://www.intellectualmedicine.com/consultation Provider training: https://www.imeduniversity.com/provider-growth-experienceYouTube: https://www.youtube.com/@intellectualmedicine Instagram: instagram.com/intellectualmedine Disclaimer: The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com
No one should face breast cancer alone. Luckily, childhood friends Caryn Siegel Finley and Tammy Leyden didn't have to. The two grew up together on Staten Island and have been best friends since they were 7 years old. When they both were diagnosed with breast cancer in their early 40's, just one year apart, they were able to support each other through the process. Caryn and Tammy are here today to share their stories with us and how they are committed to supporting those affected by breast cancer.
Lakysha was diagnosed with breast cancer in 2018. Her cancer was caught early but test results showed there was a high chance of recurrence. She required surgery, chemotherapy, radiation and a hormone blocker for five years. She also had a hysterectomy to minimize her risk of other cancers. Life is a journey for her, filled with ups and downs, new challenges and triumphs. And Vonya is the friend we all need. She's the friend who helps you reframe your bad days and encourages you to focus on something that brings you joy. She helped Lakysha normalize what she was going through and accept her emotions as they came. She's also the friend who reminds you not to let one bad day spill into the next day.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
Send us a textIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and analyst Robert Sassoon speak with Eric Poma PhD, CEO of Calidi Biotherapeutics Inc (NYSE American: CLDI). The discussion focuses on how Calidi is solving the "delivery problem" in cancer treatment, and specifically how to transport cancer-killing oncolytic viruses systemically through the bloodstream without the body's immune system neutralizing them before they reach the tumor.
In today's episode, the discussion features Jonathan R. Strosberg, MD, a professor and leader in the Neuroendocrine Tumor Division and the Department of Gastrointestinal Oncology Research Program at Moffitt Cancer Center in Tampa, Florida, who reviewed the clinical implications of peptide receptor radionuclide therapy (PRRT) with 177Lu-edotreotide (ITM-11) for patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs), drawing on efficacy and safety findings from the phase 3 COMPETE trial (NCT03049189).
There is no way around it, breast cancer is hard. But as our guest today will tell you, trying to remain upbeat throughout treatment can have a positive impact on your life. Amy Elizabeth Chalmers Hicks brings a unique perspective. She was adopted so she doesn't know her biological family's health history, leaving her to navigate two cancer diagnoses without the insights many rely on to understand risk. However, despite these unknowns, when she found a lump, she stayed at ease, started treatment right away, surrounded herself with people who were loving and supportive and made a deep commitment to keeping a positive attitude. She is here today to share her inspiring story with us.
Men often don't think of themselves as having breasts. For men, it's their chest or their “pecs.” So it may come as a surprise to learn men are at risk of breast cancer. The fact is men have breast tissue and can get breast cancer. In the U.S., less than 1% of all cases occur in men, but it does happen. Today we are joined by Jake Messier, a man living with metastatic breast cancer, after being misdiagnosed twice and finally learning in August 2024 that it had advanced. Jake openly shares his story across active social media platforms and is dedicated to spreading awareness of male breast cancer, as well as the distinct mental and physical health struggles that go largely unaddressed when a man is navigating what is typically seen as a woman's disease.
Welcome to the Oncology Brothers podcast! In this episode, we dived into the key highlights from the SABCS 2025 conference, focusing on metastatic hormone receptor-positive breast cancer. Join us as we discussed: • The role of CDK4-6 inhibitors in frontline therapy, featuring updates from the AMBRE and MONALEESA-3 studies • Insights into second-line treatment options, including the VIKTORIA-1, evERA, EMBER-3, SERENA-6 trials • A critical look at the ASCENT-07 study, exploring the role of antibody-drug conjugates (ADCs) in endocrine-resistant disease We were thrilled to have Dr. Hope Rugo, a world-renowned breast medical oncologist from City of Hope, share her expertise and insights on these pivotal studies. Tune in for an informative discussion that unpacks the latest advancements in treatment options for metastatic hormone receptor-positive breast cancer, and learn how these findings may impact clinical practice. Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to like, subscribe, and check out our other episodes for more insights on treatment algorithms, recent approvals, and conference highlights! #SABCS2025 #MBC #HRpositive #CDK46 #ADCs #OncologyBrothers
As we close out the year, we're shining a light on the quiet, powerful work happening every day inside Komen's Patient Care Center. In this special episode, we sit down with two of our remarkable patient navigators — Marcela Orozco and Ladoya Mayfield — to share the biggest impact stories of the year. From helping Spanish-speaking callers break through language barriers to supporting Houston communities facing some of the highest burdens of breast cancer, Marcela and Ladoya bring humanity, hope and heart into the lives of people going through one of their hardest moments.
In this episode of the Oncology Brothers podcast, we dived into the latest discussions surrounding metastatic colorectal cancer, focusing on treatment strategies for refractory cases. We recapped our recent discussions with GI experts, including Dr. John Strickler, Dr. Chiara Cremolini, Dr. Namrata Vijayvergia, and Dr. Tiago Biachi. Key topics included: * The importance of next-generation sequencing (NGS) and biomarker testing in treatment planning. * An overview of second-line treatment options such as Tas-102 with Bevacizumab, Regorafenib, and Fruquintinib, along with their respective clinical trial data. * Insights into side effect management and quality of life considerations for patients undergoing palliative treatment. * A discussion on the recent STELLAR-303 study and its implications for immunotherapy in colorectal cancer. Join us as we bridge the gap between academia and community practice, emphasizing the need for improved treatment options and patient care in the realm of refractory colorectal cancer. Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to subscribe for more practice-changing updates! #ColorectalCancer #mCRC #TAS102 #Regorafenib #PalliativeCare #OncologyBrothers #GIOcology
We are thrilled to be joined by the co-founder of the Home Edit. She is an Emmy-nominated, NY Times best-selling author, a mom, a wife and a breast cancer survivor - the amazing Clea Shearer. Clea is here to talk about her shocking breast cancer diagnosis at the age of 40, the ongoing reconstruction complications that she has had to endure over the past three years and the unexpected lessons that have come with all of it. Clea's new book is aptly called Cancer is Complicated and she is here to tell us all about how true that statement really is!
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb and Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb and Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb and Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb and Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.
Children can be one of life's greatest blessings. Breast cancer survivors Alex Miles-Stiffler and Sara Galher-Barlow long for larger families but their diagnoses put those dreams farther and farther out of reach. Alex struggled to start a family before her diagnosis. The heart ache she felt after two miscarriages was unbearable at times, and her fertility challenges only grew after breast cancer treatment, but she wasn't giving up on the family she dreamed of having. Sara always knew she wanted several children. She was blessed with a precious daughter prior to being diagnosed, but her cancer was aggressive and treatment couldn't wait. She had to forego egg preservation, and the uncertainty of fertility along with the cost of fertility treatments will make it harder to grow her family.
Knowledge is power, and when it comes to breast cancer, having access to accurate, up-to-date information can make all the difference. That's why Susan G. Komen is committed to providing trusted educational resources that empower patients, caregivers and families to make informed decisions about their care. Today we are joined by Jessica Thompson, who is both a survivor and health communication scientist, to walk us through where the breast cancer community can turn to find comprehensive, unbiased information, what they will find there and the vigorous review process that Komen uses to create its content, starting with their long standing partnership with Dana-Farber/Harvard Cancer Center.
Please visit answersincme.com/TDB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in colorectal cancer discusses optimizing care with immunotherapy for patients with MSI-H/dMMR disease. Upon completion of this activity, participants should be better able to: Discuss the efficacy and safety of immunotherapy-based regimens in patients with microsatellite instability high (MSI-H)/mismatch repair deficient (dMMR) advanced colorectal cancer (CRC); and Outline evidence-based strategies to optimize outcomes for patients with MSI-H/dMMR advanced CRC.
Interview with Ann Brunson, MS, and Theresa H. M. Keegan, PhD, MS, authors of Metastatic Recurrence Among Adolescents and Young Adults With Cancer. Hosted by Vivek Subbiah, MD. Related Content: Metastatic Recurrence Among Adolescents and Young Adults With Cancer Metastatic Recurrence in Adolescent and Young Adult Cancer—Key Drivers of Early Mortality
Patient navigation has become one of the most powerful tools for improving breast cancer outcomes — and in Native American communities, it can be lifesaving. From long travel distances to specialty care, to navigating complex referral systems, to ensuring communication is culturally grounded and respectful, navigation helps Native patients feel supported every step of the way. In celebration of Native American Heritage Month, we're joined by Linda Burhansstipanov, MSPH, DrPH (Cherokee Nation) — founder of the Native American Cancer Research Corp. and a pioneer in developing culturally appropriate patient navigation models for Indigenous American communities. Dr. Burhansstipanov shares insights about how navigation strengthens trust, improves follow-through on screening and treatment, and supports families and entire communities. She also breaks down practical ways health systems and partners like Komen can work together to meet people where they are and help Native patients feel seen, respected and cared for.
Breast cancer can be one of the toughest experiences anyone can face, but it can also be a transformative journey. While both the physical and emotional challenges are daunting, the path to healing offers a chance to rediscover resilience and joy in unexpected ways. Today, we are excited to welcome Aastha Saggar, a stage 3 breast cancer survivor and the founder of Still Strength Wellness, where she helps survivors, patients and caregivers reclaim peace, strength, and purpose. Aastha believes that rebuilding energy and vitality is not just possible but can be a beautiful new beginning. Get ready to be inspired as she shares her personal story, along with practical strategies that will empower our listeners to not only survive but thrive.
For many Americans, health insurance open enrollment is underway. They're deciding which coverage they need and how they can afford out-of-pocket expenses. They may be learning about high-deductible plans, health savings accounts, flexible spending accounts and so many other options when it comes to health insurance. So how do you know which plan is right for you? Joining me today is Valerie Nelson, manager of federal policy and advocacy at Susan G. Komen, and Mari Montesano, a manager at Komen's Breast Care Helpline, who assists individuals in need of information, support or help navigating their breast health issues.
Today on Real Pink, we are joined by someone w ho knows what it means to care deeply for others and what it feels like when life suddenly requires that same care and compassion be turned inward. She's a devoted mother and caregiver to her son, and when she was diagnosed with breast cancer, she found that she was more mentally prepared to navigate it than expected. Sabrina Thomas is here to tell her story, including how she advocated for herself and learned to accept help from others when she's so used to being the one who gives it. This conversation is a reminder that strength comes in many forms.
In this episode, we review the high-yield topic of Metastatic Cancer to Bone from the Oncology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
Welcome to the Komen Health Equity Revolution podcast series on Real Pink. Each month, we bring together patients, community partners, health care providers, researchers and advocates to talk about real challenges and real solutions driving the health equity revolution. Together, we're working to close the gaps and create a future of breast health equity for all. We are honored to be joined by Guerdy Abraira. You may know her from The Real Housewives of Miami, but beyond the cameras, Guerdy has shown incredible strength and resilience as a breast cancer survivor. This National Breast Cancer Awareness Month, we're talking about the power of sharing your story, building community and why organizations like Susan G. Komen are committed to ensuring that no one faces breast cancer alone.
Today we are speaking with a family who only knows life with breast cancer. With a strong family history of both breast cancer and BRCA gene mutations on the maternal side, everyone has always wondered “when”, not “if” breast cancer would affect them too. When Kathryn was diagnosed in her early 30's like her mother was, it unveiled the difficulties of being diagnosed as a young woman. It also spurred a series of decisions by her two sisters, one of which is her twin. This is a story of support, empowerment, struggle, guilt and pain, but most of all, family. Today we welcome sisters Kathryn, Christine and Cara and their mom Vicki to the show to talk about experiences.
© 2020-2026 Ivy Podcast Discovery LLC
